Skip to main content

Want a detailed portfolio tracker?

Tempest Therapeutics (TPST) P/E (2021 - 2026)

Tempest Therapeutics (TPST) P/E from Jun 30, 2021 to Jul 20, 2026. The TTM Tempest Therapeutics (TPST) P/E is -0.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Tempest Therapeutics (TPST)

YearP/EChange
2026-0.18-59.60%
2025-0.44-76.32%
2024-1.87-91.96%
2023-23.31+447.44%
2022-4.26-81.90%
2021-23.52N/A

Comparison Tempest Therapeutics (TPST) P/E with competitors

Tempest Therapeutics (TPST) P/E is -0.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.95%
NBYStablecoin Development Corp0.00-102.40%
ENLVEnlivex Ltd0.07-141.71%
FGENFibroGen Inc0.24-233.85%
CHRSCoherus Biosciences Inc0.85-573.15%
FBIOFortress Biotech Inc0.95-629.19%
ORMPOramed Pharmaceuticals Inc1.50-938.12%
AGENAgenus Inc3.01-1778.20%
INVAInnoviva Inc3.15-1858.72%
VXRTVaxart Inc3.55-2079.37%
CRMDCorMedix Inc3.63-2123.26%
CVACCureVac N.V.4.45-2578.96%
GLPGGalapagos NV4.86-2809.37%
SRPTSarepta Therapeutics Inc4.88-2822.31%
ABEOAbeona Therapeutics Inc5.39-3104.13%
ABUSArbutus Biopharma Corp5.60-3220.18%
ZVRAZevra Therapeutics Inc5.89-3382.78%
SPROSpero Therapeutics Inc6.23-3573.05%
CGENCompugen Ltd6.31-3620.73%
RIGLRigel Pharmaceuticals6.87-3931.94%
SLXNSilexion Therapeutics Corp7.30-4168.38%
OMEROmeros Corporation9.26-5262.79%
AUPHAurinia Pharmaceuticals Inc9.58-5444.69%
PLXProtalix BioTherapeutics Inc10.89-6172.95%
ACADAcadia Pharmaceuticals Inc11.73-6639.97%
TBPHTheravance Biopharma Inc12.26-6937.52%
ADMAAdma Biologics Inc12.42-7024.51%
HRMYHarmony Biosciences Holdings Inc13.82-7806.32%
SABSSAB Biotherapeutics Inc14.14-7982.53%
NAGENiagen Bioscience Inc14.82-8362.78%
INCYIncyte Corp15.82-8922.86%
REGNRegeneron Pharmaceuticals Inc15.86-8941.88%
PBYIPuma Biotechnology Inc17.32-9755.46%
CPRXCatalyst Pharmaceuticals Inc17.44-9824.39%
EXELExelixis Inc17.54-9879.43%
TGTXTG Therapeutics Inc18.97-10675.73%
MDXGMimedx Group Inc20.55-11560.35%
XOMAXOMA Royalty Corp22.87-12855.57%
ARGXArgen X SE24.30-13649.25%
CTMXCytomX Therapeutics Inc24.82-13940.94%
XOMAOXOMA Royalty Corp25.34-14232.98%
HALOHalozyme Therapeutics Inc25.62-14388.50%
XOMAPXOMA Royalty Corp25.67-14414.37%
VRTXVertex Pharmaceuticals Inc27.99-15710.65%
RPRXRoyalty Pharma plc - Class A28.69-16096.97%
SLNOSoleno Therapeutics Inc29.02-16279.77%
ASNDAscendis Pharma A/S30.09-16876.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-21240.80%
APLSApellis Pharmaceuticals Inc39.02-21859.33%
BMRNBiomarin Pharmaceutical Inc42.21-23638.51%
KRYSKrystal Biotech Inc45.34-25384.79%
ONCBeiGene Ltd69.54-38877.72%
PHARPharming Group N.V.75.03-41936.39%
TECHBio-Techne Corp101.96-56954.89%
VCELVericel Corp109.92-61395.26%
ALNYAlnylam Pharmaceuticals Inc117.96-65880.69%
GMABGenmab140.29-78330.12%
TLXTelix Pharmaceuticals Ltd162.15-90521.02%
CORTCorcept Therapeutics Inc212.86-118795.40%